1. Home
  2. WLDN vs TXG Comparison

WLDN vs TXG Comparison

Compare WLDN & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Willdan Group Inc.

WLDN

Willdan Group Inc.

HOLD

Current Price

$106.06

Market Cap

1.6B

ML Signal

HOLD

Logo 10x Genomics Inc.

TXG

10x Genomics Inc.

HOLD

Current Price

$16.36

Market Cap

1.6B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
WLDN
TXG
Founded
1964
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
2006
2019

Fundamental Metrics

Financial Performance
Metric
WLDN
TXG
Price
$106.06
$16.36
Analyst Decision
Strong Buy
Hold
Analyst Count
3
13
Target Price
$114.33
$14.96
AVG Volume (30 Days)
203.7K
2.7M
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
71.17
N/A
EPS
2.79
N/A
Revenue
$651,926,000.00
$641,814,000.00
Revenue This Year
N/A
$4.50
Revenue Next Year
$9.01
N/A
P/E Ratio
$38.75
N/A
Revenue Growth
12.90
1.92
52 Week Low
$30.43
$6.78
52 Week High
$121.00
$20.34

Technical Indicators

Market Signals
Indicator
WLDN
TXG
Relative Strength Index (RSI) 62.47 46.37
Support Level $101.66 $16.10
Resistance Level $105.88 $18.38
Average True Range (ATR) 3.98 0.97
MACD 0.75 -0.37
Stochastic Oscillator 76.45 3.18

Price Performance

Historical Comparison
WLDN
TXG

About WLDN Willdan Group Inc.

Willdan Group Inc is a provider of professional technical and consulting services to utilities, private industry, and public agencies at all levels of government. It operates in the business segments of Energy and Engineering and Consulting. It generates the majority of its revenue from the Energy segment, which includes services such as audit and surveys, program design, master planning, benchmarking analysis, design engineering, construction management, performance contracting, installation, advances in software and data analytics, and other services. All of its revenue is derived from the domestic markets.

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

Share on Social Networks: